Summary

Results from the Placement of Aortic Transcatheter Valve Trial [PARTNER B; NCT00530894] continue to support the role of transcatheter aortic valve replacement as the standard of care for symptomatic patients with aortic stenosis who are not surgical candidates, as presented 3-year follow-up findings from the PARTNER B trial.